Haemodialysis (HD) is the commonest form of kidney replacement therapy in the world,
accounting for approximately 69% of all kidney replacement therapy and 89% of all dialysis …

Patients with chronic kidney disease (CKD) frequently experience unpleasant symptoms.
These can be gastrointestinal (constipation, nausea, vomiting and diarrhoea), psychological …

Objectives To review evidence about the uptake of core outcome sets (COS). A COS is an
agreed standardized set of outcomes that should be measured and reported, as a minimum …

Outcomes reported in randomized controlled trials in peritoneal dialysis (PD) are diverse,
are measured inconsistently, and may not be important to patients, families, and clinicians …

With the growing number of dialysis patients with frailty, the concept of renal rehabilitation,
including exercise intervention and nutrition programs for patients with chronic kidney …

Chronic kidney disease (CKD), its associated symptoms, and its treatment, including
medications, dietary and fluid restrictions, and kidney replacement therapy can disrupt and …

Patient involvement in clinical trial design can facilitate the recruitment and retention of
participants as well as potentially increase the uptake of the tested intervention and the …

Background The knowledge, skills, and confidence to manage one's own health is termed
patient activation and can be assessed using the Patient Activation Measure (PAM). This …

Patient-reported outcomes (PROs) that assess individuals' perceptions of life participation,
medication adherence, disease symptoms, and therapy side effects are extremely relevant …

Shared decision-making about clinical care options in end-stage kidney disease is limited
by inconsistencies in the reporting of outcomes and the omission of patient-important …